AU2012903365A0 - Compounds for the treatment of mTOR pathway related diseases - Google Patents
Compounds for the treatment of mTOR pathway related diseasesInfo
- Publication number
- AU2012903365A0 AU2012903365A0 AU2012903365A AU2012903365A AU2012903365A0 AU 2012903365 A0 AU2012903365 A0 AU 2012903365A0 AU 2012903365 A AU2012903365 A AU 2012903365A AU 2012903365 A AU2012903365 A AU 2012903365A AU 2012903365 A0 AU2012903365 A0 AU 2012903365A0
- Authority
- AU
- Australia
- Prior art keywords
- compounds
- treatment
- related diseases
- mtor pathway
- pathway related
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000013530 TOR Serine-Threonine Kinases Human genes 0.000 title 1
- 108010065917 TOR Serine-Threonine Kinases Proteins 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 230000037361 pathway Effects 0.000 title 1
Priority Applications (20)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13827913.8A EP2880014B1 (en) | 2012-08-06 | 2013-08-05 | Compounds for the treatment of mtor pathway related diseases |
| JP2015525692A JP6441219B2 (en) | 2012-08-06 | 2013-08-05 | Compounds for treating mTOR pathway related diseases |
| HK15106070.3A HK1205502B (en) | 2012-08-06 | 2013-08-05 | Compounds for the treatment of mtor pathway related diseases |
| PCT/AU2013/000859 WO2014022879A1 (en) | 2012-08-06 | 2013-08-05 | Compounds for the treatment of mtor pathway related diseases |
| CN201510883323.4A CN105496999A (en) | 2012-08-06 | 2013-08-05 | Compounds for the treatment of mTOR pathway related diseases |
| CN201380051602.3A CN104837812B (en) | 2012-08-06 | 2013-08-05 | Compounds for treating diseases associated with mTOR pathway |
| ES13827913T ES2627099T3 (en) | 2012-08-06 | 2013-08-05 | Compounds for the treatment of diseases related to the mTOR pathway |
| PL13827913T PL2880014T3 (en) | 2012-08-06 | 2013-08-05 | Compounds for the treatment of mtor pathway related diseases |
| NZ631523A NZ631523A (en) | 2012-08-06 | 2013-08-05 | Compounds for the treatment of mtor pathway related diseases |
| NZ729555A NZ729555A (en) | 2012-08-06 | 2013-08-05 | Compounds for the treatment of mtor pathway related diseases |
| EP17162895.1A EP3202397B1 (en) | 2012-08-06 | 2013-08-05 | Compounds for the treatment of mtor pathway related diseases |
| ES17162895T ES2757598T3 (en) | 2012-08-06 | 2013-08-05 | Compounds for the treatment of diseases related to the mTOR pathway |
| US14/420,081 US9790176B2 (en) | 2012-08-06 | 2013-08-05 | Compounds for the treatment of mTOR pathway related diseases |
| KR1020157003924A KR102124392B1 (en) | 2012-08-06 | 2013-08-05 | Compounds for the treatment of mtor pathway related diseases |
| AU2013302209A AU2013302209B2 (en) | 2012-08-06 | 2013-08-05 | Compounds for the treatment of mTOR pathway related diseases |
| CA2881325A CA2881325C (en) | 2012-08-06 | 2013-08-05 | Compounds for the treatment of mtor pathway related diseases |
| ZA2015/01390A ZA201501390B (en) | 2012-08-06 | 2015-03-02 | Compounds for the treatment of mtor pathway related diseases |
| AU2016234924A AU2016234924B2 (en) | 2012-08-06 | 2016-09-28 | Compounds for the treatment of mTOR pathway related diseases |
| US15/613,635 US10053422B2 (en) | 2012-08-06 | 2017-06-05 | Compounds for the treatment of mTOR pathway related diseases |
| JP2018003249A JP6509386B2 (en) | 2012-08-06 | 2018-01-12 | Compounds for treating mTOR pathway related diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2012903365A0 true AU2012903365A0 (en) | 2012-08-23 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201402424B (en) | 1- arylcarbonyl -4 - oxy - piperidine compounds useful for the treatment of neurodegenerative diseases | |
| ZA201501390B (en) | Compounds for the treatment of mtor pathway related diseases | |
| EP2673286A1 (en) | Therapeutic compounds | |
| GB201021103D0 (en) | New compounds for the treatment of neurodegenerative diseases | |
| ZA201403795B (en) | Formulations for the treatment of diabetes | |
| PT2925757T (en) | Compounds and compositions for the treatment of parasitic diseases | |
| WO2011140517A9 (en) | Methods for treating diseases of the lung | |
| EP2994460A4 (en) | Compounds for treatment of angiogenesis-mediated diseases | |
| EP2617445B8 (en) | System for medical treatment | |
| HUP1100290A2 (en) | Combination compositions for the treatment of proliferative diseases | |
| IL234796B (en) | Compounds for the treatment of ischemia-reperfusion-related diseases | |
| PL395469A1 (en) | Indolamines derivatives for the treatment of diseases of the central nervous system | |
| AU2012903365A0 (en) | Compounds for the treatment of mTOR pathway related diseases | |
| HK40043513B (en) | Interval therapy for the treatment of eye diseases | |
| HK1193343A (en) | Methods for treating diseases of the retina | |
| HK1196953A1 (en) | Formulations for the treatment of diabetes | |
| HK1185284A (en) | Compounds for the treatment/prevention of ocular inflammatory diseases | |
| HK1188955A (en) | Methods for treating diseases of the retina | |
| HK1197236B (en) | Compounds for the treatment of addiction | |
| HK1182092A (en) | Arylosulfonamides for the treatment of cns diseases | |
| GB201009094D0 (en) | Compounds for the treatment of closridium difficile-associated disease | |
| HUP1100245A2 (en) | Pharmaceutical composition for the treatment of wounds | |
| GB201106981D0 (en) | Compounds for the treatment of clostridium difficle-associated disease | |
| GB201207476D0 (en) | pharmaceutical for the treatment of leishmaniasis | |
| HK1187328A (en) | Methods for treating neurodegenerative diseases |